The genetically encoded epitope tag provides a molecular handle on a ribosomal protein. In a tissue lysate, affinity antibodies or beads recognize that tag and capture the ribosomes carrying it. Because associated messenger RNAs remain linked to these ribosomes during purification, the tag connects the selected cellular population to the RNA recovered for downstream analysis.
Total RNA abundance reflects the messenger RNAs present in a sample, whereas TRAP enriches transcripts associated with ribosomes and therefore being translated. These measurements can differ because transcript presence does not necessarily indicate the same translation pattern. Comparing the two types of information helps distinguish changes in RNA abundance from changes specifically associated with protein synthesis.
The method uses a genetically encoded tag to mark ribosomes in selected cells or tissues, allowing their associated messenger RNAs to be recovered from a larger lysate. This avoids physically isolating rare cell populations before analysis. As a result, researchers can examine cell-specific translation patterns even when the relevant cells are difficult to separate directly.
A typical workflow begins with tissue lysis, followed by affinity capture of tagged ribosomes using antibodies or beads. The messenger RNAs associated with the captured ribosomes are then purified and analyzed, often by sequencing. This sequence of enrichment and analysis produces a cell-focused view of transcripts linked to translation rather than a general tissue RNA profile.
Sequencing the purified messenger RNAs can identify which transcripts are associated with translating ribosomes in the selected cells or tissue. The resulting profile supports comparisons of translation patterns between biological conditions or cell populations. Researchers can use those comparisons to investigate how protein synthesis changes, rather than relying only on differences in total RNA abundance.
TRAP supports studies in which translation must be resolved within organized or mixed biological samples. The approach has been applied to questions involving development, neural circuits, tissue organization, and disease-related changes in protein synthesis. Its value in these settings comes from linking cell-specific ribosome-associated messenger RNAs to broader changes in biological state.